136 related articles for article (PubMed ID: 6195792)
1. [Staging of testicular cancer by ultrasound and tumor markers with special respect to stage I and IIA].
Behrendt H; Heckemann R; Meyer-Schwickerath M; Hartung R
Urol Int; 1983; 38(5):279-84. PubMed ID: 6195792
[TBL] [Abstract][Full Text] [Related]
2. [Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors].
Behrendt H; Ringert RH; Pfeiffer R; Homann W; Hartung R
Urol Int; 1983; 38(5):307-9. PubMed ID: 6195793
[TBL] [Abstract][Full Text] [Related]
3. Testicular tumors: oncologic imaging and diagnosis.
Heiken JP; Balfe DM; McClennan BL
Int J Radiat Oncol Biol Phys; 1984 Feb; 10(2):275-87. PubMed ID: 6200463
[TBL] [Abstract][Full Text] [Related]
4. Human chorionic gonadotropin and alphafetoprotein in the staging of nonseminomatous testicular cancer.
Bosl GJ; Lange PH; Fraley EE; Goldman A; Nochomovitz LE; Rosai J; Waldmann TA; Johnson K; Kennedy BJ
Cancer; 1981 Jan; 47(2):328-32. PubMed ID: 6161691
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of preoperative staging in stages A and B nonseminomatous germ cell testis tumors.
Rowland RG; Weisman D; Williams SD; Einhorn LH; Klatte EC; Donohue JP
J Urol; 1982 Apr; 127(4):718-20. PubMed ID: 6175771
[No Abstract] [Full Text] [Related]
6. The role of tumour markers and lymphography in determining clinical stage of non-seminomatous testis tumours.
Zvara V; Hornák M; Breza J; Krídl J
Czech Med; 1986; 9(1):9-14. PubMed ID: 2423305
[TBL] [Abstract][Full Text] [Related]
7. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Beck SD; Foster RS; Bihrle R; Donohue JP
Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in metastatic nonseminomatous germ cell tumours.
Hanson PR; Belitsky P; Millard OH; Lannon SG
Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
[TBL] [Abstract][Full Text] [Related]
9. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
Skinner DG; Scardino PT
Trans Am Assoc Genitourin Surg; 1979; 71():31-5. PubMed ID: 94715
[No Abstract] [Full Text] [Related]
10. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
Swanson DA
Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
[No Abstract] [Full Text] [Related]
11. Tumor volume, CT scan, lymphography, sonography, intravenous pyelography, and tumor markers in testis tumors.
Wilbert DM; Klose KJ; Alken P; Jacobi GH; Hohenfellner R
Urol Int; 1989; 44(1):15-9. PubMed ID: 2473563
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group.
Klepp O; Olsson AM; Henrikson H; Aass N; Dahl O; Stenwig AE; Persson BE; Cavallin-Ståhl E; Fosså SD; Wahlqvist L
J Clin Oncol; 1990 Mar; 8(3):509-18. PubMed ID: 1689773
[TBL] [Abstract][Full Text] [Related]
13. Sonography and CT in staging nonseminomatous testicular tumors.
Poskitt KJ; Cooperberg PL; Sullivan LD
AJR Am J Roentgenol; 1985 May; 144(5):939-44. PubMed ID: 2580425
[TBL] [Abstract][Full Text] [Related]
14. Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients.
Dunzendorfer U; Jurincic C
Urol Int; 1987; 42(4):248-53. PubMed ID: 2445089
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
16. The place of surgery in the treatment of seminomatous testicular tumors.
Smith RB
Prog Clin Biol Res; 1984; 153():111-9. PubMed ID: 6206504
[TBL] [Abstract][Full Text] [Related]
17. Modified neck dissection for metastatic nonseminomatous testicular carcinoma.
Weisberger EC; McBride LC
Laryngoscope; 1999 Aug; 109(8):1241-4. PubMed ID: 10443827
[TBL] [Abstract][Full Text] [Related]
18. Ferritin - another tumor marker for testicular malignancies.
Engelmann U; Büber V; Riedmiller H; Jacobi GH
Eur Urol; 1981; 7(6):355-8. PubMed ID: 6169531
[TBL] [Abstract][Full Text] [Related]
19. An unusual bilateral primary tumour of the testis.
Warmenhoven PG; Groot G
Neth J Surg; 1983 Jul; 35(3):106-8. PubMed ID: 6193459
[No Abstract] [Full Text] [Related]
20. Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy.
Steyerberg EW; Keizer HJ; Sleijfer DT; Fossâ SD; Bajorin DF; Gerl A; de Wit R; Kirkels WJ; Koops HS; Habbema JD
Radiology; 2000 May; 215(2):437-44. PubMed ID: 10796922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
